Antibiotics Are Man's Greatest Invention
In May, the U.S. Department of Agriculture released new data on the use of antibiotics in U.S. operations that raise swine or feedlot cattle—information that provides crucial insights into antibiotic stewardship practices, helps identify areas for improvement, and guides policy efforts to combat antibiotic resistance….
The Pew Charitable Trusts sent a letter to Representatives Danny K. Davis (D-IL) and Kenny Marchant (R-TX) on Aug. 1 thanking them for introducing the Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms (DISARM) Act of 2019 in the House….
As of September 2017, an estimated 48 new antibiotics with the potential to treat serious bacterial infections are in clinical development. The success rate for clinical drug development is low; historical data show that, generally, only 1 in 5 infectious disease products that enter human testing (phase 1 clinical trials) will be approved for patients….
As of September 2017, an estimated 33 new nontraditional products with the potential to treat or prevent serious bacterial infections are in clinical development. Below is a snapshot of the current nontraditional products pipeline, based on publicly available information and informed by external experts….